Diabetic retinopathy: are we really doing all we can for our patients?
Although it is now possible to significantly reduce the incidence of blindness secondary to diabetes mellitus, large numbers of diabetic patients still experience visual loss due to retinal complications of the disease. This implies that protocols for the diagnosis and treatment of diabetic retinopathy used in the various multicenter trials have not yet been transferred into routine clinical practice. In countries where ocular complications of diabetes have been managed on the basis of well-codified protocols for several years, the incidence of visual loss among diabetic patients has been significantly reduced. It is absolutely essential to introduce screening and treatment protocols for diabetic retinopathy promptly everywhere. Their application is within the reach of every ophthalmologist. Patients must be informed that it is important to have regular full ophthalmological examinations, before any symptoms occur; the guidelines for screening and management of retinopathy must be known and accepted by the medical community. Spreading this information among primary care physicians, ophthalmologists and diabetologists is a fundamental step in improving the health care of the diabetic patient.
Bandello
F
F
Porta
M
M
Brancato
R
R
D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D003695:Delivery of Health Care; D003930:Diabetic Retinopathy / Q000628:therapy*; D006801:Humans; D007558:Italy; D010353:Patient Education as Topic; D019057:Quality-Adjusted Life Years